Drugs with this side effect as MedDRA Preferred Term
- 5-ASA
- Atrial fibrillation: postmarketing
- 5-aza-2'-deoxycytidine
- 5-azacytidine
- Anidulafungin
- BPTI
- Bivalirudin
- Atrial fibrillation: 1% - 1.1%
- CAS 76095-16-4
- CAS 76420-72-9
- Atrial fibrillation: postmarketing
- Cancidas
- Eptifibatide
- Atrial fibrillation: common, 0.288%
- FK463
- Atrial fibrillation: 0% - 4.95%
- Glat copolymer
- Atrial fibrillation: infrequent
- K779
- L-Dmp
- Atrial fibrillation: rare
- LMWH
- Atrial fibrillation: 0.697%
- LY146032
- Lisinopril
- Atrial fibrillation
- Atrial fibrillation and flutter: 5.3% - 6.4%
- Optison
- Atrial fibrillation: postmarketing
- PCI-32765
- Photofrin
- Atrial fibrillation: 9% - 10%
- Photofrin II
- Atrial fibrillation: uncommon
- Terlipressin
- Atrial fibrillation: postmarketing
- UDCA
- adenosine
- Atrial fibrillation: postmarketing
- alfuzosin
- Atrial fibrillation: very rare, postmarketing
- amifostine
- aminophylline
- Atrial fibrillation: 1% - 12%
- amiodarone
- Atrial fibrillation: 0.881% - 1.84%
- amlodipine
- amlodipine besylate
- amoxapine
- Atrial fibrillation: postmarketing
- amphotericin B
- amsacrine
- anagrelide
- anthracycline
- argatroban
- Atrial fibrillation: 3% - 11.4%
- aripiprazole
- arsenic trioxide
- atenolol
- Atrial fibrillation: 4.92% - 29%
- atropine
- azelastine
- Atrial fibrillation: postmarketing
- bicalutamide
- bisoprolol
- boceprevir
- Atrial fibrillation: rare
- bortezomib
- Fibrillation atrial aggravated
- bosentan
- busulfan
- cabazitaxel
- cabozantinib
- capecitabine
- carnitine
- Atrial fibrillation: 2% - 6%
- carvedilol
- Atrial fibrillation: 2.2% - 4.3%
- cilazapril
- cilostazol
- ciprofloxacin
- citalopram
- Atrial fibrillation: postmarketing, rare, uncommon
- cladribine
- Atrial fibrillation: rare
- clarithromycin
- clevidipine
- Atrial fibrillation: 12.2% - 21.3%
- conivaptan
- Atrial fibrillation: 2.7%
- copolymer 1
- cyclophosphamide
- Atrial fibrillation: postmarketing
- dasatinib
- Atrial fibrillation: postmarketing
- deferiprone
- Atrial fibrillation: postmarketing
- degarelix
- deprenyl
- Atrial fibrillation: infrequent
- desflurane
- Atrial fibrillation: postmarketing
- dexmedetomidine
- Atrial fibrillation: postmarketing, 4% - 7%
- dipyridamole
- Atrial fibrillation: 0.1%
- docetaxel
- Atrial fibrillation: postmarketing, rare
- donepezil
- Atrial fibrillation: infrequent, frequent
- dopamine
- doxazosin
- duloxetine
- Atrial fibrillation: infrequent
- eletriptan
- Atrial fibrillation: rare
- entacapone
- eplerenone
- Atrial fibrillation: uncommon
- eprosartan
- ertapenem
- etoricoxib
- etravirine
- everolimus
- febuxostat
- felbamate
- fenofibrate
- fenoprofen
- Atrial fibrillation: postmarketing
- fexofenadine
- fluoxetine
- Atrial fibrillation: postmarketing, rare
- fluticasone/salmeterol
- Atrial fibrillation: uncommon
- fluvastatin
- fondaparinux
- Atrial fibrillation: 1.03% - 3.02%
- formoterol
- Atrial fibrillation: postmarketing, rare
- gabapentin
- Atrial fibrillation: rare
- gadobenate dimeglumine
- gadofosveset
- galantamine
- Atrial fibrillation: infrequent
- gefitinib
- gemfibrozil
- Atrial fibrillation: postmarketing, 0.7%
- glycopyrrolate
- Atrial fibrillation: uncommon
- granisetron
- Atrial fibrillation: rare
- guanidinium
- hydrochlorothiazide
- idarubicin
- ifosfamide
- Atrial fibrillation: postmarketing
- imatinib
- Atrial fibrillation: rare
- imiquimod
- Atrial fibrillation: postmarketing, 0.905% - 1.4%
- indacaterol
- Atrial fibrillation: uncommon
- indapamide
- iodixanol
- iopromide
- Atrial fibrillation: postmarketing
- ioxilan
- ipratropium bromide
- Atrial fibrillation: postmarketing, rare
- isomannide
- isosorbide-5-mononitrate
- isradipine
- ivabradine
- lacosamide
- Atrial fibrillation: postmarketing
- lamotrigine
- Atrial fibrillation: rare
- lenalidomide
- Atrial fibrillation: postmarketing, 3.12% - 3.68%
- Fibrillation atrial aggravated
- leuprorelin acetate
- levosimendan
- losartan
- melphalan
- memantine
- Atrial fibrillation: postmarketing, infrequent
- metipranolol
- metoclopramide
- mirabegron
- Atrial fibrillation: 0.2%
- morphine
- moxifloxacin
- mycophenolate mofetil
- mycophenolic acid
- naltrexone
- naratriptan
- Atrial fibrillation: infrequent
- niacin
- Atrial fibrillation: postmarketing
- nicardipine
- nicotine
- nifedipine
- nilotinib
- Atrial fibrillation: uncommon, common
- nisoldipine
- ofloxacin
- olanzapine
- Atrial fibrillation: infrequent
- olodaterol
- ondansetron
- Atrial fibrillation: postmarketing
- paclitaxel
- Atrial fibrillation: very rare, postmarketing, common
- paliperidone
- Atrial fibrillation: very rare, postmarketing
- pamidronate
- Atrial fibrillation: common, 0% - 6%
- pantoprazole
- paroxetine
- Atrial fibrillation: postmarketing, rare
- pergolide
- Atrial fibrillation: infrequent
- pomalidomide
- Atrial fibrillation: 1.87% - 2.68%
- ponatinib
- posaconazole
- Atrial fibrillation
- Fibrillation atrial aggravated
- pramipexole
- prasugrel
- Atrial fibrillation: 2.9% - 3.1%
- pregabalin
- Atrial fibrillation: infrequent
- procainamide
- propafenone
- Atrial fibrillation: 0.4% - 1%
- Paroxysmal atrial fibrillation: postmarketing
- propofol
- quetiapine
- Atrial fibrillation: rare
- raltitrexed
- ramipril
- rapamycin
- regadenoson
- Atrial fibrillation: postmarketing, uncommon
- remifentanil
- Atrial fibrillation: 0% - 18.8%
- riluzole
- Atrial fibrillation: infrequent
- risperidone
- Atrial fibrillation: postmarketing
- rivastigmine
- Atrial fibrillation: postmarketing, infrequent, uncommon, frequent
- rofecoxib
- roflumilast
- ropinirole
- ropivacaine
- salbutamol
- Atrial fibrillation: very rare, postmarketing, rare
- salmeterol
- Atrial fibrillation: very rare, postmarketing
- sevoflurane
- sibutramine
- sildenafil
- Atrial fibrillation: postmarketing, rare
- simvastatin
- Atrial fibrillation: 5.7%
- solifenacin
- Atrial fibrillation: postmarketing
- sparfloxacin
- sumatriptan
- Atrial fibrillation: postmarketing
- tacrolimus
- Atrial fibrillation: postmarketing
- tamsulosin
- Atrial fibrillation: postmarketing
- telavancin
- Atrial fibrillation: uncommon
- telmisartan
- Atrial fibrillation: postmarketing
- terazosin
- Atrial fibrillation: postmarketing
- thalidomide
- Atrial fibrillation: postmarketing, 4.7%
- theophylline
- Atrial fibrillation: 1% - 12%
- ticagrelor
- Atrial fibrillation: 4.2% - 4.6%
- tigecycline
- tolcapone
- Atrial fibrillation: infrequent
- torasemide
- tramadol
- Atrial fibrillation: postmarketing, uncommon
- tranexamic acid
- trazodone
- Atrial fibrillation: postmarketing
- umeclidinium
- valdecoxib
- valsartan
- vandetanib
- Atrial fibrillation: 0.4%
- varenicline
- Atrial fibrillation: rare, uncommon
- vemurafenib
- venlafaxine
- Atrial fibrillation: postmarketing
- verteporfin
- voriconazole
- zalcitabine
- ziconotide
- Atrial fibrillation: uncommon
- ziprasidone
- Atrial fibrillation: infrequent
- zoledronic acid
- Atrial fibrillation: uncommon, 2% - 3.3%
- zolmitriptan
- Atrial fibrillation: rare
- zonisamide
- Atrial fibrillation: rare
|
Drugs with this indication
|